Cargando…
Activation of K-RAS by co-mutation of codons 19 and 20 is transforming
The K-RAS oncogene is widely mutated in human cancers. Activating mutations in K-RAS give rise to constitutive signalling through the MAPK/ERK and PI3K/AKT pathways promoting increased cell division, reduced apoptosis and transformation. The majority of activating mutations in K-RAS are located in c...
Autores principales: | Naguib, Adam, Wilson, Catherine H, Adams , David J, Arends, Mark J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056876/ https://www.ncbi.nlm.nih.gov/pubmed/21371307 http://dx.doi.org/10.1186/1750-2187-6-2 |
Ejemplares similares
-
K-ras oncogene codon 12 point mutations in testicular cancer.
por: Ridanpää, M, et al.
Publicado: (1993) -
Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study
por: Naguib, Adam, et al.
Publicado: (2010) -
Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.
por: Capella, G, et al.
Publicado: (1991) -
Acute sensitivity of the oral mucosa to oncogenic K-ras
por: van der Weyden, Louise, et al.
Publicado: (2011) -
Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
por: Smith, G, et al.
Publicado: (2010)